ARQT
Arcutis Biotherapeutics Inc · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website arcutis.com
- Employees(FY) 268
- ISIN US03969K1088
Performance
+14.71%
1W
-8.91%
1M
-1.08%
3M
+371.79%
6M
+184.83%
YTD
-8.09%
1Y
Profile
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical formulation of ivarmacitinib designed to reach deeper into the skin in order to treat alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Investment Analysis Report: ARQT
Overview
In this investment analysis report, we will delve into the financial statements of ARQT, a company in the Health Technology sector specializing in Pharmaceuticals. We will analyze the company's valuation, financial health, earnings and revenue growth, profitability, operating margin, operating cash flow,...
Technical Analysis of ARQT 2024-05-10
Overview:
In analyzing the technical indicators for ARQT over the last 5 days, we will delve into the trends, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and recommendations for your invest...
Recent News & Updates
- 2024-05-16 11:23
- 2024-05-15 12:54
Q1 2024 Arcutis Biotherapeutics Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-05-15 12:03
- 2024-05-15 04:24
- 2024-05-15 03:13
- 2024-05-14 21:12
Sector Update: Health Care Stocks Rise Pre-Bell Wednesday(Yahoo Finance)
- 2024-05-14 20:53
Sector Update: Health Care(Yahoo Finance)
- 2024-05-14 20:46
- 2024-05-14 20:19
- 2024-05-14 19:29
- 2024-05-14 16:53
- 2024-05-14 16:00
- 2024-05-14 08:57
- 2024-05-14 04:00
- 2024-05-13 08:00
- 2024-05-12 20:00
- 2024-05-03 16:00
- 2024-05-03 04:00
- 2024-04-29 16:00
- 2024-04-29 04:00
- 2024-04-26 06:11
- 2024-04-24 09:40
- 2024-04-10 08:00
Arcutis Appoints David Topper as Chief Financial Officer(GlobeNewswire)
- 2024-04-09 20:00
Arcutis Appoints David Topper as Chief Financial Officer(Globenewswire)
- 2024-04-08 09:40
- 2024-04-05 16:00
- 2024-04-05 04:00
- 2024-04-01 07:00
- 2024-03-31 19:00
- 2024-03-28 08:00
Page 1 of 7
previousnext